Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time–Kill Approaches
Open Access
- 4 December 2021
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 10 (12) , 1485
Abstract
Antibiotic dosing strategies are generally based on systemic drug concentrations. However, drug concentrations at the infection site drive antimicrobial effect, and efficacy predictions and dosing strategies should be based on these concentrations. We set out to review different translational pharmacokinetic-pharmacodynamic (PK/PD) approaches from a target site perspective. The most common approach involves calculating the probability of attaining animal-derived PK/PD index targets, which link PK parameters to antimicrobial susceptibility measures. This approach is time efficient but ignores some aspects of the shape of the PK profile and inter-species differences in drug clearance and distribution, and provides no information on the PD time-course. Time–kill curves, in contrast, depict bacterial response over time. In vitro dynamic time–kill setups allow for the evaluation of bacterial response to clinical PK profiles, but are not representative of the infection site environment. The translational value of in vivo time–kill experiments, conversely, is limited from a PK perspective. Computational PK/PD models, especially when developed using both in vitro and in vivo data and coupled to target site PK models, can bridge translational gaps in both PK and PD. Ultimately, clinical PK and experimental and computational tools should be combined to tailor antibiotic treatment strategies to the site of infection.Keywords
Funding Information
- H2020 Marie Skłodowska-Curie Actions (861323)
This publication has 156 references indexed in Scilit:
- Quantitative Impact of Neutrophils on Bacterial Clearance in a Murine Pneumonia ModelAntimicrobial Agents and Chemotherapy, 2011
- Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose OptimizationAntimicrobial Agents and Chemotherapy, 2011
- Efficacy of Human Simulated Exposures of Ceftaroline Administered at 600 Milligrams Every 12 Hours against Phenotypically Diverse Staphylococcus aureus IsolatesAntimicrobial Agents and Chemotherapy, 2011
- Meropenem Penetration into Epithelial Lining Fluid in Mice and Humans and Delineation of Exposure TargetsAntimicrobial Agents and Chemotherapy, 2011
- Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection ModelAntimicrobial Agents and Chemotherapy, 2010
- Pharmacodynamics of Levofloxacin in a Murine Pneumonia Model of Pseudomonas aeruginosa Infection: Determination of Epithelial Lining Fluid TargetsAntimicrobial Agents and Chemotherapy, 2009
- Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with CeftobiproleAntimicrobial Agents and Chemotherapy, 2009
- Functional relationship between bacterial cell density and the efficacy of antibioticsJournal of Antimicrobial Chemotherapy, 2009
- In Vivo Microdialysis Study of the Penetration of Daptomycin into Soft Tissues in Diabetic versus Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2008
- The Relationship between Quinolone Exposures and Resistance Amplification Is Characterized by an Inverted U: a New Paradigm for Optimizing Pharmacodynamics To Counterselect ResistanceAntimicrobial Agents and Chemotherapy, 2007